MedTrace Logo

Painless Laser Therapy for Overactive Bladder

NCT01569061 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2012-04-02

No results posted yet for this study

Summary

The primary objective of this study is to determine the effectiveness of transvaginally-delivered low level laser therapy (LLLT) versus Sham in the treatment of overactive bladder symptoms in women. The secondary objective is to determine the effect of transvaginally-delivered LLLT vs. sham on the quality of life.

Conditions

Interventions

DEVICE

LCT-1000TM (Manufacturer: LiteCure)

low level laser therapy (LLLT)

DEVICE

LCT-1000TM (Manufacturer: LiteCure)

low level laser therapy (LLLT) sham treatment

Sponsors & Collaborators

  • Zipper Urogynecology Associates

    lead OTHER

Principal Investigators

  • Ralph Zipper, MD · Zipper Urogynecology Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-08-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569061 on ClinicalTrials.gov